Search

everythinglearnresearchcommunity

for

Search:↓

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Some therapies using stem cells and platelet-rich plasma may help treat osteoarthritis, but more research is needed to ensure they are safe and effective.

Clascoterone safely promotes hair growth similar to minoxidil.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Topical finasteride is an effective and safer treatment for male hair loss.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

PLD is an effective and safer alternative for treating breast cancer.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.